Search Results 851-860 of 17084 for nivolumab
About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...
... nivolumab. The researchers showed that this combination of virotherapy and immunotherapy significantly increased the survival of mice with malignant brain ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Giving ixazomib with pomalidomide and dexamethasone may be an effective treatment for relapsed or relapsed/refractory multiple myeloma. Participation ...
About this study. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated ...
Learn more about the symptoms, diagnosis and treatment of neuroblastoma, one of the most common cancers of childhood.
Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...
Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.
Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!